SynthesisObesity surgery2023
Indocyanine Green in Bariatric Surgery: a Systematic Review.
Synthesis in Obesity surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Real-time endoscopic tissue oxygen saturation imaging of the upper gastrointestinal tract: baseline values and association with gastrojejunal anastomotic ulcer healing.Surgical endoscopy · 2026Article
- Global Technical Variations in Roux-en-Y Gastric Bypass: A Worldwide Survey Among IFSO Members.Obesity surgery · 2026Article
- Fluorescence-Guided Surgery in Metabolic and Bariatric Surgery: Current Status and Future Directions.Obesity surgery · 2025Article
- Are We Adopting New Technologies in MBS to Serve the Patients or Because They Fascinate the Surgeon?Obesity surgery · 2025Article
- Laparoscopic Upper Polar Esophagogastrectomy with Gastroplasty Using Gastric Remnant After Roux-en-Y Gastric Bypass for Recurrent Gastroesophageal Junction Adenocarcinoma.Obesity surgery · 2025Article
- Real-Time Perfusion and Leak Assessment in Bariatric Surgery: Bridging Traditional and Advanced Techniques.Cureus · 2024Review
- A Green Lantern for the Surgeon: A Review on the Use of Indocyanine Green (ICG) in Minimally Invasive Surgery.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indocyanine green (ICG) is a fluorescent dye that can be used intraoperatively to assess tissue perfusion, as well as perform leak testing. This study aims to summarize published manuscripts on outcomes of ICG use and reduction of complications compared to traditional leak test and tissue perfusion evaluation. A PubMed search using "ICG and bariatric surgery," "ICG and gastric sleeve," "ICG and gastric bypass," and "ICG and revisional bariatric surgery" was performed. The proportion of patients who underwent an intraoperative decision change due to ICG was 3.8% (95% CI: 2.0 to 7.2%). ICG fluorescent imaging in bariatric surgery is a valuable tool, and further studies are needed to confirm its utility for routine use in both standard or complex cases (PROSPERO #418126).
Indexed as
Identifiers
37713041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.